Search
LivaNova PLC
LIVNAdd to Watchlist
82.230USD
-0.830-1.00%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
4.52BMarket Cap
41.59P/E TTM
More Details of LivaNova PLC Company
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
LivaNova PLC Info
Ticker SymbolLIVN
Company nameLivaNova PLC
IPO dateOct 19, 2015
CEOMakatsaria (Vladimir A)
Number of employees2900
Security typeOrdinary Share
Fiscal year-endOct 19
Address20 Eastbourne Terrace
CityLONDON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeW2 6LG
Phone442033250662
Websitehttps://www.livanova.com/
Ticker SymbolLIVN
IPO dateOct 19, 2015
CEOMakatsaria (Vladimir A)
Company Executives of LivaNova PLC
Name
Name/Position
Position
Shareholding
Change
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
37.57K
+13.31%
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
12.62K
+28.18%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
9.79K
+36.33%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.58K
+24.58%
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
6.80K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
6.09K
+31.74%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
37.57K
+13.31%
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
12.62K
+28.18%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
FAQs
Who are the top five shareholders of LivaNova PLC?
The top five shareholders of LivaNova PLC are: Mr. Alex Shvartsburg
How many institutions hold shares of LivaNova PLC (LIVN)?
As of 2026Q1, 609 institutions hold shares of LivaNova PLC, with a combined market value of approximately 60.49M, accounting for 110.12% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -11258417.00.
